The case revolves around Novartis' contention that MSN's generic contains small amounts of crystalline forms of the active ingredients in Entresto that would infringe a patent on the drug (No.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillationAcquisition adds a late-stage asset and is aligned with Novartis strategic focus ...

Job Title Sort ascending Business Location Site Date Posted Therapeutic Area Partner Regular (Sales), Full time Innovative Medicines Utd.Arab Emir. Dubai Feb 03, 2025 Senior Specialist, IT Information ...

In a report released today, James Quigley from Goldman Sachs maintained a Hold rating on Novartis AG (NOVN – Research Report), with a price target of CHF98.00. Leverage the power of TipRanks ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 2,146.62 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

During his stroll through radio row at the Super Bowl on Wednesday, Nacua was asked by Sports Illustrated to draw the Rams’ logo. His attempt proves he has no idea what it looks like ...